ArticleThe Journal of international medical research2026
Correlation of neutrophil- and high-density lipoprotein cholesterol-related inflammatory markers with sarcopenia: Insights from a cross-sectional study.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivesThis study aimed to comprehensively investigate the possible associations between neutrophil- and high-density lipoprotein cholesterol (HDL-C)-related inflammatory markers and the incidence of sarcopenia among adults in the United States.MethodsThis cross-sectional study analyzed data from 8878 participants in the National Health and Nutrition Examination Survey. The potential associations between neutrophil- and HDL-C-related inflammatory markers and sarcopenia were evaluated using multiple statistical methods, including weighted logistic regression analysis, sensitivity analyses, restricted cubic spline models, and subgroup analyses. A receiver operating characteristic curve was employed to thoroughly analyze the predictive accuracy of various inflammatory markers for sarcopenia risk.ResultsAll examined inflammatory markers were significantly associated with sarcopenia. The association between the neutrophil-to-HDL-C ratio and sarcopenia was nonlinear, with risk increasing notably beyond a certain threshold (breakpoint = 2.791), whereas the neutrophil percentage-to-albumin ratio demonstrated a linear association. Further threshold effect analyses identified specific breakpoints for neutrophil-to-HDL-C ratio, platelet-to-HDL-C ratio, lymphocyte-to-HDL-C ratio, and monocyte-to-HDL-C ratio. Notably, the area under the curve value for neutrophil-to-HDL-C ratio exceeded those for other inflammatory markers in receiver operating characteristic analysis (area under the curve = 0.632, 95% confidence interval: 0.612-0.652), suggesting its potential as a promising predictor of sarcopenia prevalence.ConclusionsThe findings suggest positive associations between inflammatory biomarkers and sarcopenia, with the neutrophil-to-HDL-C ratio demonstrating superior predictive performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.